Geneva Capital Management LLC Sells 6,068 Shares of Azenta, Inc. (NASDAQ:AZTA)

Geneva Capital Management LLC lessened its position in Azenta, Inc. (NASDAQ:AZTA) by 1.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 488,642 shares of the company’s stock after selling 6,068 shares during the period. Geneva Capital Management LLC owned about 1.07% of Azenta worth $24,432,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Farther Finance Advisors LLC boosted its holdings in shares of Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after buying an additional 256 shares during the period. KBC Group NV boosted its holdings in shares of Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company’s stock worth $107,000 after buying an additional 698 shares during the period. Assenagon Asset Management S.A. bought a new stake in shares of Azenta during the 4th quarter worth about $200,000. Aigen Investment Management LP bought a new stake in shares of Azenta during the 3rd quarter worth about $214,000. Finally, Empowered Funds LLC bought a new stake in shares of Azenta during the 4th quarter worth about $293,000. Institutional investors own 99.08% of the company’s stock.

Wall Street Analysts Forecast Growth

AZTA has been the subject of several research analyst reports. Needham & Company LLC lifted their target price on shares of Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a report on Thursday, February 6th. Stephens reaffirmed an “overweight” rating and set a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd. Evercore ISI lifted their target price on shares of Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a report on Thursday, February 6th. Finally, TD Cowen raised shares of Azenta to a “hold” rating in a report on Thursday, February 27th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $58.75.

Azenta Stock Down 0.3 %

NASDAQ AZTA opened at $40.94 on Thursday. The company has a market capitalization of $1.87 billion, a P/E ratio of -13.74 and a beta of 1.47. Azenta, Inc. has a 12-month low of $38.82 and a 12-month high of $67.77. The firm has a 50-day moving average price of $49.80 and a two-hundred day moving average price of $47.55.

Azenta (NASDAQ:AZTA) last issued its earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Equities analysts expect that Azenta, Inc. will post 0.53 EPS for the current year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.